NEUROTRANSMITTER AGENTS
Clinical trials for NEUROTRANSMITTER AGENTS explained in plain language.
Never miss a new study
Get alerted when new NEUROTRANSMITTER AGENTS trials appear
Sign up with your email to follow new studies for NEUROTRANSMITTER AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Treatment-Resistant depression: Fast-Acting drug trial launches
Symptom relief Recruiting nowThis study tests whether a new drug called HNK can quickly improve symptoms in people with major depression that hasn't responded to other treatments. About 50 adults aged 18 to 70 will receive four infusions of HNK and four of a placebo over several weeks, with their depression …
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New injection could smooth away neck bands
Symptom relief Recruiting nowThis phase 3 trial tests whether NT 201 (a botulinum toxin injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either NT 201 or a placebo injection. The study measures improvem…
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Could a ketamine mist lift severe depression fast?
Symptom relief Recruiting nowThis study tests whether inhaling ketamine through a nebulizer can quickly reduce symptoms of moderate to severe depression in hospitalized adults. About 40 participants will receive either ketamine or a placebo (midazolam) and be monitored for changes in depression scores over 8…
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
NIH launches study to uncover clues in mood disorder treatments
Knowledge-focused Recruiting nowThis study follows 500 adults already receiving care for depression, bipolar disorder, or suicide risk at the NIH. Researchers will conduct weekly interviews and optional tests like blood draws and brain scans to track symptoms and treatment responses. The goal is to better under…
Matched conditions: NEUROTRANSMITTER AGENTS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC